Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

Financing Life Sciences

Financing Life Sciences - Debt, Royalty and Related Funding Structures

Covington has a leading life sciences finance practice, representing numerous life sciences and healthcare investors, along with biotech and healthcare companies looking to access capital in this market. Our experience encompasses debt and royalty financings for venture, growth oriented, and established companies.

This content hub is a resource for up-to-date information on this rapidly evolving market.

Share links:

Share links:

Royalty Monetization Study
Read More
Second Annual Synthetic Royalty and Drug Development Financing Study
Read More
Financing Life Sciences - A Pocket Guide
Read More
In re Mallinckrodt Update—Third Circuit Agrees with Lower Courts: Royalty Obligations Not Tied to IP License Are Dischargeable Unsecured Claims
Read More
Structuring Royalty Monetizations - Bankruptcy and the Risk of Contract Rejection
Read More
Royalty Rights as Unsecured Claims
Read More
PhaseBio – A Drug Development Financing (Almost) Tested in Bankruptcy
Read More
Your Guide to Synthetic Drug Royalty Dealmaking
Read More

Our Team

Peter Schwartz

Partner

Julian Wright

Special Counsel

Martin Beeler

Of Counsel

Jennifer Uren

Partner

Brent Little

Of Counsel

Amy Toro

Partner

 

Explore More Areas of Interest

 
Finance

Covington has a sophisticated finance practice active in public and private credit markets.

Learn More 
 
Life Sciences

Covington offers one of the largest and most comprehensive life sciences industry-focused practices in the world.

Learn More  

News and Insights

Events